Is Ibuprofen recalled?
68 FDA recalls mention Ibuprofen. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Ibuprofen.
Class II · Moderate risk Terminated Sep 27, 2019
Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Class II · Moderate risk Terminated Sep 27, 2019
Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Class II · Moderate risk Terminated Sep 27, 2019
Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Class II · Moderate risk Terminated Sep 27, 2019
Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Class II · Moderate risk Terminated Sep 27, 2019
Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Class II · Moderate risk Terminated May 21, 2019
Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Class II · Moderate risk Terminated Jan 15, 2019
Reason Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.
Class II · Moderate risk Terminated Jan 15, 2019
Reason Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.
Class II · Moderate risk Terminated Jan 15, 2019
Reason Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.
Class II · Moderate risk Terminated Nov 26, 2018
Reason Superpotent Drug: recalled lots may have higher concentration of ibuprofen.
Class II · Moderate risk Terminated Nov 26, 2018
Reason Superpotent Drug: recalled lots may have higher concentration of ibuprofen.
Class II · Moderate risk Terminated Nov 26, 2018
Reason Superpotent Drug: recalled lots may have higher concentration of ibuprofen.
Class II · Moderate risk Terminated Aug 23, 2018
Reason Labeling Error: Not elsewhere classified. product has a dosage cup marked in teaspoons and the instructions on the label are described in…
Class II · Moderate risk Terminated Jan 25, 2018
Reason CGMP deviations.
Class II · Moderate risk Terminated Jan 11, 2018
Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Class II · Moderate risk Terminated Jan 11, 2018
Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Class II · Moderate risk Terminated Jan 11, 2018
Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Class II · Moderate risk Terminated Jan 11, 2018
Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Class II · Moderate risk Terminated Jan 11, 2018
Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Class II · Moderate risk Terminated Jan 11, 2018
Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Class II · Moderate risk Terminated Jan 11, 2018
Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Class II · Moderate risk Terminated Jan 11, 2018
Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Class II · Moderate risk Terminated Jan 11, 2018
Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Class II · Moderate risk Terminated Jan 11, 2018
Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Class II · Moderate risk Terminated Jan 11, 2018
Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.